Literature DB >> 7453967

Large and giant aneurysms.

H W Pia.   

Abstract

In a retrospective review about large and giant aneurysms of the literature and the own material (51 large and 19 giant aneurysms) the problems of distribution, diagnosis, and treatment are discussed. The present classification and interpretation are arbitrary and imprecise; size and form, site, origin, and projection have not been taken into consideration. A special analysis and a combined study of large and giant aneurysms are lacking. The own material discussed concerns distribution and classification as well as clinical and neuroradiological findings in the different locations of these aneurysms. The main locations are for large aneurysms ICA (17%), MCA (about 10%), and VBA (about 9%), and for giant aneurysms 3.5%, 3.6%, and 8.6% respectively. The relative distribution for giant aneurysms are ICA with about 50%, ACA with 20%, and VBA with 20% too. The management of giant aneurysms and to a lesser extent of large aneurysms as well is unsatisfactory. The results are discussed. The development of CT-scanning and microsurgery with arterial bypass operations and intracranial artery sutures has improved the therapeutic possibilities tremendously. Some cases are briefly discussed. The prospective personal strategy in handling large and giant aneurysms by direct attack or a combined procedure with external-internal artery bypass operation and a direct occlusion and excision in a second stage have been described. Because of the limited experience, a cooperative prospective study of interpretation, classification, clinical data, course, and therapy of such aneurysms in a representative group of patients is necessary.

Entities:  

Mesh:

Year:  1980        PMID: 7453967     DOI: 10.1007/bf01644413

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  19 in total

1.  Large intracranial aneurysms.

Authors:  O Heiskanen; P Nikki
Journal:  Acta Neurol Scand       Date:  1962       Impact factor: 3.209

2.  Aneurysms of the middle cerebral artery.

Authors:  E CAMPBELL; C W BURKLUND
Journal:  Ann Surg       Date:  1953-01       Impact factor: 12.969

3.  Giant intracranial aneurysms: a review of 13 cases.

Authors:  V K Sonntag; R H Yuan; B M Stein
Journal:  Surg Neurol       Date:  1977-08

4.  Ligation of the vertebral (unilateral or bilateral) or basilar artery in the treatment of large intracranial aneurysms.

Authors:  C G Drake
Journal:  J Neurosurg       Date:  1975-09       Impact factor: 5.115

5.  Aneurysmal tumors of the basifrontal region.

Authors:  R E Maxwell; S N Chou
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

6.  Giant aneurysm of the middle cerebral artery.

Authors:  J F Howe; A B Harris; G W Sypert
Journal:  Surg Neurol       Date:  1976-10

7.  Large suprasellar aneurysms imitating pituitary tumour.

Authors:  L A Raymond; J Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-01       Impact factor: 10.154

8.  Posterior fossa aneurysms simulating tumours.

Authors:  W F Michael
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-02       Impact factor: 10.154

9.  Classification of vertebro-basilar aneurysms.

Authors:  H W Pia
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

10.  Foramen magnum syndrome caused by a giant aneurysm of the posterior inferior cerebral artery. Case report.

Authors:  D Judice; E D Connolly
Journal:  J Neurosurg       Date:  1978-04       Impact factor: 5.115

View more
  3 in total

Review 1.  Giant cerebral aneurysms.

Authors:  H W Pia; J Zierski
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

2.  Symptomatic unruptured giant aneurysms: medical treatment.

Authors:  P S Slosberg
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  The future role of neurosurgery in the case of vascular diseases of the central nervous system.

Authors:  H W Pia
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.